- Home
- / HeartFlow
HeartFlow
Revenue
$176 M
FY, 2025
HeartFlow Summary
Company Summary
- Overview
- HeartFlow is a medical technology company specializing in diagnosing and managing coronary artery disease. It develops HeartFlow Analysis, a non-invasive cardiac test that offers visualization of coronary arteries, and HeartFlow ONE, a coronary care solution including anatomy, physiology, and plaque analysis, based on coronary computed tomography angiography (CCTA).
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Mountain View, CA, US | view all locations
- Website
- https://www.heartflow.com
- Cybersecurity rating
Table of Contents
Key People
Charles A. Taylor, Founder, Chief Scientific Officer, and Directors
Stephanie Heller, Chief Human Resources Officer
Vikram Verghese, Chief Financial Officer
Operating MetricsView all
Trademarks (US)
3
May, 2024
Product Categories
5
May, 2024
Patients
250K
May, 2024
LocationsView all
5 locations detected
Mountain View, CA HQ
United States
331 E Evelyn Ave
Austin, TX
United States
4516 Seton Center Pkwy
Portland, OR
United States
1355 NW Everett Street
Tokyo, Tokyo
Japan
1 Chome-18-6 Nishishinbashi, Cross Office Uchisaiwaicho 13F
London, England
United Kingdom
100 New Bridge Street
HeartFlow Financials
Summary Financials
- Revenue (FY, 2025)
- $176.0M
- Gross profit (FY, 2025)
- $135.2M
- Net income (FY, 2025)
- ($116.8M)
- Cash (FY, 2025)
- $44.8M
- EBIT (FY, 2025)
- ($64.1M)